Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/<scp>mTOR</scp>/p70S6K and TGFβ/Smad signalling pathways

Abstract

This study demonstrates that luteolin prevents the progression of liver fibrosis through multiple mechanisms and indicates that luteolin has potential for effective treatment of liver fibrosis.